Burning Rock Announces The Resignation Of Mr. Leo Li As A Director And As The Co's CFO, Effective September 27, 2024; Concurrently, Ms. Xiaozhi Hu Will Be In Charge Of Financial Operations
Burning Rock Announces The Resignation Of Mr. Leo Li As A Director And As The Co's CFO, Effective September 27, 2024; Concurrently, Ms. Xiaozhi Hu Will Be In Charge Of Financial Operations
Burning Rock Biotech Limited (NASDAQ:BNR) (the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced the resignation of Mr. Leo Li as a director from the Company's board of directors (the "Board") and as the Company's chief financial officer, effective September 27, 2024.
燃石醫學有限公司（納斯達克股票代碼：BNR）（以下簡稱「公司」或「燃石」），是一家致力於在精準腫瘤領域應用下一代測序（NGS）技術的公司，今天宣佈董事會主席兼首席財務官李德敬先生將於2024年9月27日正式辭去公司董事會董事一職以及公司的首席財務官一職。
Mr. Li has confirmed that his resignation was for personal reasons and not due to any disagreement with the Board, the Company or any of its affiliates on any matter relating to the Company's operations, policies or practices. Mr. Li further confirmed that he has no claims against the Company whatsoever, whether in respect of fees, remuneration or compensation for loss of office.
李先生已確認他的辭職是出於個人原因，並非因與董事會、公司或其附屬公司在公司運營、政策或實踐事項上發生任何分歧。李先生進一步確認，他對公司沒有任何索賠，無論是涉及費用、報酬還是因職務損失而進行的補償。
Concurrently, Ms. Xiaozhi Hu, senior director in finance of the Company, will be in charge of financial operations, financial reporting and related matters of the Company, and report directly to Mr. Yusheng Han, chairman of the board and chief executive officer of the Company. Ms. Hu joined the Company in May 2014 and has extensive experience in financial management.
與此同時，公司財務高級總監胡小芝將負責公司財務運營、財務報告及相關事宜，並直接向董事長兼首席執行官韓玉生先生彙報。胡女士於2014年5月加入公司，在財務管理方面擁有豐富經驗。
